regulation is the sole category represented across all 1 tracked stories. Dan Neidle is most often covered alongside AstraZeneca, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dan Neidle
regulation is the sole category represented across all 1 tracked stories. Dan Neidle is most often covered alongside AstraZeneca, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window. At 7, the average consequence score sits below the same-window beat average of 7.1. Dan Neidle appears in 1 tracked Legal story from March 14, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 44 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dan Neidle. Shared-story counts are live from our verified record — not editorial picks.
The UK’s Companies House has taken its WebFiling service offline following the discovery of a critical security flaw that allowed users to view and edit sensitive personal data of company directors. The vulnerability, which could be exploited simply by using a browser's back button, has raised significant concerns regarding corporate identity theft and the integrity of the UK's business register.
